InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the detailed record of transactions filed by Pavliv Leo, Vice-Président Senior et Directeur du Développement. Director active across 1 companies, notably Cumberland Pharmaceuticals INC. Aggregated, 3 disclosures have been published. The latest transaction was disclosed on 31 May 2022 — J. Regulator: SEC (Form 4). All data is openly available.
Declarations3 total
€65,22733,500 shares@ €1.94710.080% mcap80.8% of flow
Common Stock
SEC:0001209191-22-040113:0·
€7,7652,870 shares@ €2.70550.0095% mcap9.6% of flow
Common Stock
SEC:0001209191-21-039925:0·
€7,7652,870 shares@ €2.70550.0095% mcap100.0% of flow
Common Stock
SEC:0001209191-21-039925·
3 of 3 declarations
About Pavliv Leo
Leo Pavliv is Senior Vice President and Chief Development Officer at Cumberland Pharmaceuticals Inc. He oversees the company's strategic development and growth initiatives, playing a key role in optimizing operations and products.
